HUTCHMED (China) (HMDCF) Total Non-Current Liabilities (2015 - 2025)

HUTCHMED (China) (HMDCF) reported Total Non-Current Liabilities of $51.3 million for Q4 2025, down 16.87% year-over-year from $61.7 million in Q4 2024, and down 88.36% quarter-over-quarter from $441.0 million in Q2 2025.

HUTCHMED (China) (HMDCF) Total Non-Current Liabilities (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has 11 years of Total Non-Current Liabilities data on file, last reported at $51.3 million in Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $51.3 million, down 16.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $51.3 million (down 16.87% YoY), and the FY2025 annual result was $5.0 million, up 28.69% from the prior year.
  • Total Non-Current Liabilities fell to $51.3 million in Q4 2025 per HMDCF's latest filing, from $441.0 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $441.0 million in Q2 2025 and troughed at -$2.8 billion in Q4 2023.
  • A 5-year average of -$118.2 million and a median of $61.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities jumped 774.28% in 2021, then plunged 6148.6% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $35.8 million in 2021, then surged by 31.16% to $47.0 million in 2022, then slumped by 6148.6% to -$2.8 billion in 2023, then surged by 102.17% to $61.7 million in 2024, then slipped by 16.87% to $51.3 million in 2025.
  • Business Quant data shows HMDCF's Total Non-Current Liabilities at $51.3 million in Q4 2025, $441.0 million in Q2 2025, and $61.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 HUTCHMED (China) - - - 51.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 51.32 Mn
Jun 30, 2025 440.98 Mn
Dec 31, 2024 61.74 Mn
Jun 30, 2024 61.85 Mn
Dec 31, 2023 -2.84 Bn
Jun 30, 2023 44.16 Mn
Dec 31, 2022 46.96 Mn
Jun 30, 2022 322.27 Mn
Dec 31, 2021 35.81 Mn
Jun 30, 2021 253.67 Mn
Mar 31, 2021 221.92 Mn
Dec 31, 2020 6.74 Mn
Jun 30, 2020 -37.62 Mn
Dec 31, 2019 48.69 Mn
Sep 30, 2019 108.85 Mn
Jun 30, 2019 114.32 Mn
Mar 31, 2019 130.61 Mn
Dec 31, 2018 117.46 Mn
Jun 30, 2018 117.25 Mn
Dec 31, 2017 -18.75 Mn